Celltrion
068270.KS
£96.55
Share price
0.17%
Change (1 day)
-13.99%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Cash on Hand
Cash on Hand as of December 2024 : £0.58 Billion
According to Celltrion
's latest financial reports the company has £0.58 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Celltrion - Cash on Hand chart (from 2007 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | £0.62 B | 35.04% |
| 2023-12-31 | £0.45 B | 17.95% |
| 2022-12-31 | £0.38 B | -48.69% |
| 2021-12-31 | £0.75 B | 61.06% |
| 2020-12-31 | £0.47 B | 13.89% |
| 2019-12-31 | £0.41 B | 10.24% |
| 2018-12-31 | £0.37 B | -3.01% |
| 2017-12-31 | £0.38 B | 110.08% |
| 2016-12-31 | £0.18 B | 105.92% |
| 2015-12-31 | £89.51 M | 28.82% |
| 2014-12-31 | £69.48 M | 6.82% |
| 2013-12-31 | £65.05 M | 5.8% |
| 2012-12-31 | £61.48 M | 88.96% |
| 2011-12-31 | £32.53 M | -53.97% |
| 2010-12-31 | £70.68 M | 499.11% |
| 2009-12-31 | £11.79 M | 412.36% |
| 2008-12-31 | £2.3 M | 0.39% |
| 2007-12-31 | £2.29 M |